Fig. 1 · Structure
Documents & Downloads
PD 130908
Radiosensitizer
PD 130908 is an orally active hypoxic cell radiosensitizer that enhances the effects of radiation therapy in tumor environments. Its potent radiosensitizing activity makes it a valuable tool in cancer research for studying mechanisms of tumor response to radiation. PD 130908 aids in the investigation of hypoxia-related pathways and the development of combination therapies to improve patient outcomes in radiation oncology.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 131505-02-7 |
| Applications | Radiosensitizer |
| Formula | C8H14Br2N4O2 |
| Molecular Weight | 358.03 |
| SMILES | O=[N+]([O-])C1=NC=CN1CCCNCCBr.[H]Br |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.